Multiple myeloma and bone: The fatal interaction

Silvia Marino, G. David Roodman

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Multiple myeloma (MM) is the second-most-common hematologic malignancy and the most frequent cancer to involve bone. MM bone disease (MMBD) has devastating consequences for patients, including dramatic bone loss, severe bone pain, and pathological fractures that markedly decrease the quality of life and impact survival ofMMpatients.MMBDresults from excessive osteoclastic bone resorption and persistent suppressed osteoblastic bone formation, causing lytic lesions that do not heal, even when patients are in complete and prolonged remission. This review discusses the cellular and molecular mechanisms that regulate the uncoupling of bone remodeling in MM, the effects of MMBD on tumor growth, and potential therapeutic approaches that may prevent severe bone loss and repair damaged bone in MM patients.

Original languageEnglish (US)
Article numbera031286
JournalCold Spring Harbor Perspectives in Medicine
Issue number8
StatePublished - Aug 1 2018

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Multiple myeloma and bone: The fatal interaction'. Together they form a unique fingerprint.

Cite this